Fulgent Genetics, Inc. to Present at the 25th Annual Credit Suisse Healthcare Conference on November 7, 2016
25 oct. 2016 08h05 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) (“Fulgent Genetics” or the “company”) today announced that Ming Hsieh, its Chairman and Chief...
Fulgent Genetics, Inc. Announces Full Exercise of Option to Purchase Additional Shares in its Initial Public Offering
07 oct. 2016 16h05 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 07, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) announced today that the underwriters of its previously announced...
Fulgent Genetics, Inc. Announces Closing of Initial Public Offering
04 oct. 2016 16h05 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics (Nasdaq:FLGT) announced today the closing of its initial public offering of 4,200,000 shares of common stock at a public...
Fulgent Genetics, Inc. Announces Pricing of Initial Public Offering
28 sept. 2016 19h01 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics announced today the pricing of its initial public offering of 4,200,000 shares of its common stock at a public offering price...
Fulgent Genetics Files Registration Statement for Initial Public Offering
06 sept. 2016 11h42 HE
|
Fulgent Genetics, Inc.
TEMPLE CITY, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed...